DDMC

DDMC (4-dedimethylaminodemeclocycline) is a chemically modified, non-antibiotic derivative of the tetracycline antibiotic demeclocycline. It is primarily recognized for its neuroprotective properties, specifically its ability to rescue dopaminergic neurons from iron-dependent ferroptosis, a form of regulated cell death characterized by lipid peroxidation. Unlike its parent compound, DDMC lacks antimicrobial activity, making it a candidate for long-term therapeutic use in chronic neurodegenerative conditions without the risks associated with chronic antibiotic exposure. Its mechanism involves the mitigation of intracellular oxidative stress and the prevention of mitochondrial membrane depolarization. Research suggests that DDMC is particularly effective against chronic, low-intensity oxidative insults, such as those occurring in the progression of Parkinson's disease.

Other names

4-dedimethylaminodemeclocycline4-de(dimethylamino)demeclocycline